Assessing the Value of 18F-Fluciclovine PET/CT in the Assessment of Pancreatic Transplants
Latest Information Update: 06 Sep 2024
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Pancreatic disorders
- Focus Diagnostic use
- 20 Dec 2023 Status changed from active, no longer recruiting to completed.
- 11 Oct 2023 Planned End Date changed from 31 Aug 2022 to 31 Aug 2024.
- 11 Oct 2023 Planned primary completion date changed from 30 Apr 2022 to 30 Apr 2024.